Process Analytical Technology Advances and Applications in Recombinant Protein Cell Culture Processes

The Food and Drug Administration (FDA) recognition that process optimization in industry may be delayed or never happen to minimize regulatory risks is an excellent first step toward application of emerging technologies by the industry. Nevertheless, the success of this strategy will only be possible if the FDA and other regulatory agencies place an equal amount of effort in ensuring communication, openness, and the right support to the industry.